Concerns about data reporting and interpretation in "Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial".

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Marks, DM; Abramowitz, JS; Spielmans, GI

Published Date

  • May 2012

Published In

Volume / Issue

  • 46 / 5

Start / End Page

  • 692 - 693

PubMed ID

  • 22520251

Pubmed Central ID

  • 22520251

Electronic International Standard Serial Number (EISSN)

  • 1879-1379

Digital Object Identifier (DOI)

  • 10.1016/j.jpsychires.2012.02.002

Language

  • eng

Conference Location

  • England